BioCentury
ARTICLE | Finance

BiomX’s balance

How BiomX attracted Seventure, other microbiome investors to A round

May 19, 2017 8:43 PM UTC

After identifying a handful of novel bacterial targets and bacteriophage candidates, BiomX Ltd. was able to attract $24 million in series A funding from some of industry's most active microbiome players.

OrbiMed Advisors, the Johnson & Johnson Innovation - JJDC Inc. unit of Johnson & Johnson (NYSE:JNJ) and Takeda Ventures co-led the round, which closed on May 15. Seventure Partners, Mirae Asset, SBI Japan-Israel Innovation Fund and undisclosed European investors participated. ...

BCIQ Company Profiles

BiomX Inc.